Fabino Enterprises Ltd Stock Price Today (NSE: FABINO)
Fundamental Score
Fabino Enterprises Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Fabino Enterprises Ltd share price today is ₹20.31, up +0.00% on NSE/BSE as of 22 September 2026. Fabino Enterprises Ltd (FABINO) is a Small-cap company in the Pharmaceuticals & Biotechnology sector with a market capitalisation of ₹4.27 (Cr). The 52-week high for FABINO share price is ₹27.00 and the 52-week low is ₹13.01. The company has a Return on Equity (ROE) of -9.17% and a debt-to-equity ratio of 0.45.
Fabino Enterprises Ltd Share Price Chart — NSE/BSE Historical Performance
Fabino Enterprises Ltd share price chart: 0.00% return over the past month. 52-week high ₹27.00, 52-week low ₹13.01.
Fabino Enterprises Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | 0.00 (Cr) | |
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | 0.00 (Cr) | |
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | 0.00 (Cr) | |
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | 0.00 (Cr) | |
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | 0.00 (Cr) | |
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | 0.00 (Cr) | |
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | 0.00 (Cr) | |
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | 0.00 (Cr) | |
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | 0.00 (Cr) | |
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | 0.00 (Cr) |
Fabino Enterprises Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | +0.00% | |
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | +0.00% | |
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | +0.00% | |
| ₹20.31 | ₹20.31 | ₹20.31 | ₹20.31 | +0.00% | |
| ₹15.94 | ₹20.31 | ₹15.94 | ₹20.31 | +27.42% | |
| ₹13.10 | ₹15.43 | ₹13.10 | ₹15.19 | +15.95% | |
| ₹13.77 | ₹14.45 | ₹13.10 | ₹13.10 | -4.87% | |
| ₹20.75 | ₹20.75 | ₹13.01 | ₹13.98 | -32.63% | |
| ₹23.00 | ₹27.00 | ₹15.22 | ₹20.75 | -9.78% | |
| ₹23.00 | ₹23.00 | ₹23.00 | ₹23.00 | +0.00% | |
| ₹24.25 | ₹24.25 | ₹23.00 | ₹23.00 | -5.15% | |
| ₹25.48 | ₹25.48 | ₹24.25 | ₹24.25 | -4.83% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Fabino Enterprises Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Fabino Enterprises Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of FABINO across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Balanced Promoter Holding (56.82%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Below-Average Return on Equity (-9.17%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-10.75%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-1222.89%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Interest Coverage (-4.61x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Fabino Enterprises Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Fabino Enterprises Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Fabino Enterprises LtdFabino Enterpri...Selected✓ FABINO • 543444 | 32/100 | ₹20.31₹20 | ₹4.27₹4.27 | — — | -9.17%Poor -9.17% Poor | -10.75%Poor -10.75% Poor | 0.45Excellent 0.4 Excellent | — — | — — | 0.00% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1840.00₹1840 | ₹441471.20₹441471.20 | 36.51Average 36.5 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9322.00₹9322 | ₹247033.00₹247033.00 | 84.58Average 84.6 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4965.50₹4966 | ₹168062.31₹168062.31 | 79.32Average 79.3 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1119.10₹1119 | ₹111686.18₹111686.18 | 24.94Average 24.9 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1366.00₹1366 | ₹110352.31₹110352.31 | 32.73Average 32.7 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1969.00₹1969 | ₹106375.23₹106375.23 | 97.19Average 97.2 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1165.50₹1166 | ₹97319.25₹97319.25 | 30.12Average 30.1 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1679.80₹1680 | ₹96655.69₹96655.69 | 26.25Average 26.2 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2095.00₹2095 | ₹95793.88₹95793.88 | 17.31Average 17.3 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2280.00₹2280 | ₹94164.00₹94164.00 | 46.07Average 46.1 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price441471.20 Cr
- Divi's Laboratories Limited share price247033.00 Cr
- Torrent Pharmaceuticals Limited share price168062.31 Cr
- Zydus Lifesciences Limited share price111686.18 Cr
- Cipla Limited share price110352.31 Cr
Fabino Enterprises Ltd PE Ratio History
Historical price-to-earnings ratio for FABINO — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.17 | ₹32.90 | 193.5x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Fabino Enterprises Ltd Quarterly Performance
Latest quarterly metrics for FABINO — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
3.06%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-1222.89%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Fabino Enterprises Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for FABINO — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Fabino Enterprises Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Fabino Enterprises Ltd (FABINO) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Fabino Enterprises Ltd
About FABINO (Fabino Enterprises Ltd)
Fabino Enterprises Ltd is a dynamic and multifaceted pharmaceutical company headquartered in India, driven by a commitment to enhance health and well-being. With a diversified appr...oach, FABINO engages in the complete life cycle of pharmaceutical products, from meticulous manufacturing and rigorous quality control to strategic marketing and efficient distribution. Their portfolio encompasses a wide spectrum of allopathic and herbal formulations, addressing numerous therapeutic areas with tablets, syrups, ointments, and more. FABINO prides itself on delivering accessible and reliable healthcare solutions to meet the evolving needs of the Indian population, establishing a reputation for quality and innovation in the pharmaceutical landscape. Beyond pharmaceuticals, FABINO extends its reach into the realm of consumer wellness, offering a range of food and wellness products under its established Fabino and Keepshine brands. These products cater to a growing consumer demand for health-conscious choices, reflecting FABINO's dedication to holistic well-being. Their wellness line spans from nutritional supplements to everyday essentials, all formulated with a focus on quality and efficacy. This strategic diversification into consumer goods allows FABINO to connect with a broader audience, fostering brand loyalty and expanding its market presence beyond the traditional pharmaceutical sector. FABINO Enterprises Ltd also actively participates in the global market through exports, expanding its reach and impact beyond Indian borders. Their export portfolio includes a diverse array of wellness and fast-moving consumer goods (FMCG), encompassing products like coffee, malt powder, protein powder, and hair shampoo. By leveraging its manufacturing capabilities and quality standards, FABINO caters to international demands while solidifying its position as a competitive player in the global market. This international outlook further demonstrates FABINO's commitment to innovation, growth, and contributing to wellness on a global scale.
Company Details
Key Leadership
FABINO Share Price: Frequently Asked Questions
What is the current share price of Fabino Enterprises Ltd?
Fabino Enterprises Ltd (FABINO) trades at ₹20.31 on NSE and BSE. Market cap ₹4.27 (Cr). Educational data only.
What is the P/E ratio of Fabino Enterprises Ltd?
Fabino Enterprises Ltd has a P/E of N/Ax vs industry average 33.97x.
What is the Bull Run score for Fabino Enterprises Ltd?
Fabino Enterprises Ltd has a Bull Run score of 32/100 based on 25+ financial parameters.
Does Fabino Enterprises Ltd pay dividends?
Fabino Enterprises Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Fabino Enterprises Ltd?
Fabino Enterprises Ltd has ROE of -9.17%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Fabino Enterprises Ltd?
Fabino Enterprises Ltd has debt-to-equity of 0.45.
Is Fabino Enterprises Ltd a good investment?
Bull Run gives Fabino Enterprises Ltd a score of 32/100. This is not investment advice — consult a SEBI-registered advisor.